Financials
Financial year 2025
Pharma Works from Herzele, company number BE0599765351, closed financial year 2025 with a result of € 5,085 after tax. For that financial year Pharma Works recorded a gross margin of € 57,526 and equity of € 53,000. Compared with financial year 2024, the result moved from € 19,165 to € 5,085. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on October 26, 2026.
€ 53,000
▲ 11% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 5,085
▼ 73% vs 2024
Profit after tax over the fiscal year.
€ 133,770
▼ 2% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 50,500.
People and assets in 2025
€ 2,481
▼ 51% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 213,254
▼ 22% vs 2024
Loans from banks and other lenders, long and short.
€ 1,096
▼ 37% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,440
▲ 37% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 49,765 | € 89,281 | € 88,415 | € 57,526 | ▼ 35% |
| Profit after taxes | € 2,660 | € 2,204 | € 19,165 | € 5,085 | ▼ 73% |
| Equity | € 26,545 | € 28,749 | € 47,914 | € 53,000 | ▲ 11% |
| Total debts | € 343,870 | € 299,606 | € 300,183 | € 238,886 | ▼ 20% |
| Cash | € 42,327 | € 86,989 | € 136,451 | € 133,770 | ▼ 2% |
| Land & buildings | € 58,407 | € 38,690 | € 47,567 | € 42,039 | ▼ 12% |
| Retained profit | € 24,045 | € 26,249 | € 45,414 | € 50,500 | ▲ 11% |
| Bank debt | € 335,000 | € 287,288 | € 274,918 | € 213,254 | ▼ 22% |
| Balance sheet total | € 390,414 | € 336,355 | € 356,098 | € 291,886 | ▼ 18% |
Key figures of Pharma Works, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma Works?
What happened at Pharma Works in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 5,085 (▼ 73% vs 2024). filed late Source: NBB ↗
- New establishment in Herzele. KBO
- New establishment in Herzele. KBO
- Start of the company according to the CBE. KBO
- Stefaan VAN DE WALLE became a director. NBB
- Martine VAN DER BRACHT became a director. NBB
In short
From € 2,660 profit in 2022 to € 5,085 profit in 2025.
Paid € 15,458 in corporate taxes since 2022.
Best year ever: 2024, with € 19,165 profit.
Management
Behind Pharma Works are Stefaan VAN DE WALLE and Martine VAN DER BRACHT.
Directors
According to the 2025 annual accounts
Stefaan VAN DE WALLE
Director
since 2015
Martine VAN DER BRACHT
Director
since 2015
Establishments
Establishment units
Physical locations of this company
Markt 21
9550 Herzele
Groenlaan 6 box A
9550 Herzele
Active since 15 December 2022
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0599.765.351
- VAT number
- BE 0599.765.351
- Registered office
- Markt 21, 9550 Herzele
- Names & denominations
- Pharma Works
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 February 2015
- Peppol
- Active · Active since 8 Jan 2026
- Activities · NACE
Overige onderwijsondersteunende dienstverlening
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Detailhandel in vaste, vloeibare en gasvormige brandstoffen, muv motorbrandstoffen
Overige detailhandel, niet in winkels en exclusief markt- en straathandel